NUZ 6.25% 22.5¢ neurizon therapeutics limited

Ann: Epichem's New Laboratory Completed, page-95

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,429 Posts.
    lightbulb Created with Sketch. 1510
    At this point in time I cannot see them making any more progress reports on PPL-1 trials, even in dogs, until the major report on the phase 1 human trials are released or the go ahead for the phase 2 clinical trials are announced, which I hope is soon(ish).
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.